WorthlessViews

WorthlessViews Updated 

Celcius Holdings NASDAQ:CELH suffered quite a drop over the last 5 months, but it was highly overvalued. While I still view it as fairly overvalued with a P/E of 28x, it's reporting itself as a healthy company, almost no debt, with a bright growth future. Going into earnings, it could have a nice run, but I am staying highly cautious. From a technical analysis...

WorthlessViews

Match Group NASDAQ:MTCH is finally at an attractive valuation with ~13 P/E after a stunning rise that started in 2017. The amount of data this company has on its users in such a particular niche will be highly valuable as the world moves toward AI and AI matchmaking. Once large investors realize this, I (personally) feel this stock will 3x or more in the coming...

WorthlessViews Updated 

1-800-Flowers.com NASDAQ:FLWS has been in price consolidation mode since 2022 and may be gearing up for an upward move as my historical selected simple moving average reconnects with the price. The company is expected to become profitable in 2025 and the holiday season is approaching. Historically, this is the period when the price begins to rise. With a 25...

WorthlessViews Updated 

First, from a technical analysis perspective, NASDAQ:LYFT has not "officially" found a bottom yet. No one can confidently state it has - their guess is as good as yours. This analysis is full of caution simply around the fact this stock could absolutely dip to below $5.00 in the future. With that said, NASDAQ:LYFT is currently the #3 travel app in the Apple...

WorthlessViews Updated 

iHeartMedia NASDAQ:IHRT has been beat down, but I anticipate it may be on a path toward profitability during this US election cycle. This ad revenue may lead to the beginning of a nice move upward from the $1 range (a personal buy zone), but nothing is certain. Target #1 - $2.25 Target #2 - $4.00

WorthlessViews Updated 

Humana NYSE:HUM took a nosedive to "crash" levels (based on my selected simple moving averages (SMA)) this morning after a lower-performance rating for a widely used Medicare insurance plan is expected to hurt enrollments for 2025 (and will potentially hit the health insurer's revenue and bonus payments in 2026). However, I view this massive drop as an...

WorthlessViews Updated 

I'll be the contrarian. Spirit Airlines NYSE:SAVE has been beat to a pulp, but the company is still actively flying the high skies. While low-budget airlines have hit a rough patch as low-income consumers tighten their spending, the CFO recently was awarded almost $250k in options (a bullish sign). Plus, the next few years could be great for airlines as interest...

WorthlessViews Updated 

Baxter International NYSE:BAX , a company that primarily focuses on products to treat kidney disease and other chronic and acute medical conditions, is another name that had a very rough time through 2022 and into 2024. However, the company's projected earnings and cash flow are expected to grow from 2024 through 2027 and it currently has a 3.35% dividend....

WorthlessViews

HighPeak Energy NASDAQ:HPK currently has a 19.5million float, 24%+ short interest, 12x P/E, and debt/equity ratio of 0.7x... all while insiders are loading up on shares (CEO grabbed $5+ million in August 2024). Something may be brewing. The oil and natural gas company's earnings are expected to rise into 2025 after taking a hit in 2024. From a technical...

WorthlessViews Updated 

Historically, September is one of the worst performing months in the stock market. A hedge against my bets for this month is to buy shares of Direxion Daily S&P 500 High Beta Bear 3X AMEX:HIBS as a volatility play. The index provider selects 100 securities from the S&P 500 Index that have exhibited the highest sensitivity to market movements, or “beta,” over the...

WorthlessViews

Dollar Tree NASDAQ:DLTR has taken a massive hit to its stock price as low-income spenders are cutting back (recession red flag, anyone?). It recently touched my selected "crash" simple moving average area (white lines on the chart) and may take many years before true recovery occurs. However, the Director recently bought $150k+ in shares after this recent drop,...

WorthlessViews Updated 

Liberty Media Corp NASDAQ:LSXMA may have just double bottomed near $20. If so, it could mark the beginnings of a turnaround in price (especially during this political season). However, I am staying cautious. Warren Buffet was diving into this name a little too early for my taste, but now it is in a personal buy zone if it can stay above the $20 mark in the...

WorthlessViews

GrowGeneration NASDAQ:GRWG is approaching one of my favorite technical analysis setups as it gets closer to my selected historical simple moving average (SMA: the white and teal lines). Often, but not always (i.e. public offering news...), the price will jump to the selected historical SMA after a long period of consolidation - which has been occurring for some...

WorthlessViews Updated 

BlackSky Technology NYSE:BKSY is a small company focused on satellite imagery tech. It's another name from the SPAC-boom era that suffered a massive price drop - reaching a high of $17.41 in 2021 and a low of $0.86 in 2024. However, based on my selected simple moving averages (SMAs), there may be a price "influx" soon as it merges with its primary SMA (white...

WorthlessViews

Dollar General NYSE:DG took a massive hit this morning after revising their future earnings guidance. The economy is showing many signs of a recession, and this is a clear warning. From a technical analysis perspective, it has retouched my "crash" simple moving average and may dip further into the $80's in the near-term. But, like many overall strong companies...

WorthlessViews

Sabre Corporation's NASDAQ:SABR earnings have slowly been improving since the pandemic and may be heading into profitability by 2025/2026. Disinterest in the stock may also be waning as the price creeps closer to my selected historical simple moving average (SMA, white and teal lines). Often, but not always, as the price nears this line, it jumps to make contact...

WorthlessViews

Abbott Laboratories NYSE:ABT has been making higher highs and lower lows over the last year, potentially signaling a reversal in its downward trend. Monkeypox and the return of cold/flu/COVID season may spark another run to close the price gap on the daily chart around $140. It is currently in a personal buy zone at $110.00. Target #1 = $118.00 Target #2 = $140.00

WorthlessViews

NYSE:WEX Inc has a 40.8M float and recently initiated a $300 million share buyback. The stock has been in consolidation mode for some time and is playing "nicely" along my selected historical simple moving average (SMA). Recently, it may have double-bottomed off this SMA and, given the buyback, may move progressively up toward the $230's where there is a large...